Determination of (S)- and (R)-2-oxo-3-methylvaleric acid in plasma of patients with maple syrup urine disease

Clin Chim Acta. 1992 Jun 15;208(1-2):85-91. doi: 10.1016/0009-8981(92)90024-k.

Abstract

An enzymatic method for the separate measurement of both chiral 2-oxo-3-methylvaleric acid (OMV) compounds, (S)- and (R)-OMV, by NADH-dependent enantioselective amination using leucine dehydrogenase in the presence of a NADH regenerating system is described. This method allows the quantitative determination of all branched-chain 2-oxo acids, simultaneously. In plasma samples from classical maple syrup urine disease patients under therapy the average (R)-OMV/(S)-OMV ratio was 0.35 and great differences in the transamination equilibria of the diastereomeric branched-chain amino acids L-isoleucine and L-alloisoleucine were demonstrated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Oxidoreductases
  • Humans
  • Keto Acids / blood*
  • Keto Acids / chemistry
  • Leucine Dehydrogenase
  • Maple Syrup Urine Disease / blood*
  • NAD

Substances

  • Keto Acids
  • NAD
  • alpha-keto-beta-methylvaleric acid
  • Amino Acid Oxidoreductases
  • Leucine Dehydrogenase